Introduction
============

Assessing and measuring the burden of a disease in medical practice is undoubtedly important for the evaluation of medicines and healthcare.[@b1]To assess such burden quantitatively, both the prevalence of diseases and their impact on health status and on the quality of life (QOL) of patients need to be taken into account.[@b2]

In primary care, the prevalence of morbidities has been shown to be remarkably similar across different industrialised countries.[@b3; @b4; @b5] However, their effect upon QOL is only partially known.[@b6] The impact of the diseases on QOL in general practice has been addressed so far using selected samples of patients,[@b7; @b8; @b9; @b10; @b11; @b12; @b13] usually from studies including a limited number of medical practices,[@b8] [@b10] [@b11] [@b13] and/or mainly focused on chronic conditions.[@b7] [@b9; @b10; @b11] To the best of our knowledge, no nationwide study of the burden of disease combining both prevalence measures and QOL assessment for a large variety of diseases is currently available. To compensate for this paucity of information, some studies have evaluated the impact for diseases in primary care calling upon modelling data derived from studies in medical specialties[@b14; @b15; @b16] and/or in hospital settings,[@b17] [@b18] or from general population surveys.[@b19; @b20; @b21] It is not known to what extent these extrapolations are appropriate.

The aim of the Etude épidémiologique de l\'Impact de santé public sur 3 groupes de pathologies (EPI3) survey was to provide reference figures for disease burden in primary care. For this purpose, a representative sample of general practitioners (GPs) was assembled through stratified sampling and data from their patients collated during a 1-day survey conducted by independent interviewers in the waiting room of the participating medical practices.

Methods
=======

Study design, settings and population
-------------------------------------

The EPI3 survey was a nationwide, observational study of a representative sample of GPs and their patients, conducted in France between March 2007 and July 2008. Its aims were to assess the burden of diseases in general practice, considering the physicians\' work activity, patients\' characteristics, morbidity and prescriptions.

The sample was drawn by applying a two-stage sampling process. First, GPs were randomly selected from the French national directory of physicians and invited to participate, which meant also allowing a trained research assistant to conduct a 1-day survey in the waiting room at the doctor\'s practice. GPs\' sampling was stratified according to the diversity of medicine practices in the country (conventional and complementary medicine such as homeopathy).

The second stage consisted of random 1-day sampling of consultations per participating physician in order to survey all patients attending the practice on a particular day. All adult and accompanied minor patients were eligible for inclusion in the EPI3 survey to the exception of those whose health status or literacy level did not allow responding to a self-administered questionnaire. The research assistant recruited up to a maximum of 15 patients on site (ie, in the waiting room) all eligible patients listed consecutively who consented to participate in the survey. Further, each physician recorded the main reason for consultation, along with the age, gender and type of national health insurance for each patient. The maximum number of patients surveyed per day was set to allow sufficient time for optimal interviews and was followed by patients\' examination by the physician.

The EPI3 survey obtained regulatory approval by the national board of physicians ('Conseil National de l\'Ordre des Médecins') and ethical approval by the French data protection authority ('Commission Nationale de l\'Informatique et des Libertés'). Patients were informed by the participating physician that their responses would be kept confidential, and they were not remunerated for participation. Physicians received compensation fees. The study was sponsored by a pharmaceutical company, whose name was not revealed to investigators or patients.

Data collection
---------------

Patients were asked to self-complete a questionnaire covering demographic and social information (age, gender, educational level, employment status and occupation, smoking, alcohol intake, physical activity, height and weight for body mass index calculation), health insurance (regular national insurance, welfare health insurance for low income, with or without supplementary private insurance), number of visits to the participating physician within the last 12 months, or, for the same period, to other GPs or medical specialists, the length and number of hospitalisations and sick leaves.

Participants were asked whether the attending physician was their regular/primary care physician. In the French health insurance system, patients have to choose a regular physician, usually a GP, who plays a gatekeeping role for referral to specialised care. However, referral by regular GPs to other physicians is not compulsory, and patients are allowed to seek care from different physicians and their different reimbursement schemes.

Detailed information on physicians including age, gender, type of contract with national health insurance (regular fees, additional fees and no contract), working days and average duration of consultation were assessed by the research assistants at the time of inclusion.

GPs completed a medical questionnaire on patients including the main reason for consultation and up to five other diagnoses present that day. GPs were requested to record their prescriptions that day for diagnostic tests, drugs and referrals. Diagnoses were coded by a trained archivist using the ninth revision of the International Classification of Diseases using 100-3 digit-categories.[@b22]

Health-status measurement
-------------------------

Among adult patients (18 years and over), health-related quality of life was assessed using the 12-Item Short Form questionnaire (SF-12),[@b23] a shortened version of the 36-Item Short Form Health Survey (SF-36) which has been shown to be a reliable outcome measurement tool in primary care.[@b24] The physical and mental component summary scores (PCS and MCS, respectively) were derived from the SF-12 questionnaire. Physical functioning (two questions), role---physical functioning (two questions), bodily pain (one question), general health (one question), vitality (one question), social functioning (one question), role---emotional functioning (two questions) and mental health (two questions) cover the same dimensions as the SF-36. The scores are standardised to population norms (based on a US norm-sample), with the mean score set at 50 (SD 10); lower scores indicate worse health, and higher scores better health. The SF-12 has been validated for use in France, the USA, the UK and many other European countries.[@b21]

Statistical analysis
--------------------

Participating and non-participating patients were compared against the collected variables on gender, age, length of time attending the GPs\' practice, type of health insurance and main reason for consultation. A weighting procedure known in demographic studies as the CALMAR (CALage sur MARges) procedure was applied to calibrate the final sample according to participation so that it closely represents the patients attending the practice.[@b25]

Participating GPs were compared with the French 'Institut de recherche et documentation en économie de la santé' sample.[@b26]The physicians\' activity-related fractions were also calibrated to the real distribution of the participating physicians across the France. All reported results were obtained after weighting was applied to GPs\' patients.

In this study, we reported weighted prevalence, calculated as a percentage reported to the whole population, regardless of whether the diagnosis was isolated or associated with other diagnoses. Weighted PCS and MCS measures of the SF-12 were computed according to the algorithm given by Ware *et al* for 100 different conditions, which were further grouped into 13 broad diseases categories plus one covering preventive motives of consultation and other medical acts.[@b23] Means and SDs were estimated for the whole adult sample and for each diagnosis. When a three-digit category from the ninth revision of the International Classification of Diseases had \<30 patients, the category was grouped with one or several categories under the same heading. When grouping within the same heading was not relevant, categories with \<30 patients were grouped in the category 'other' within each main category.

Each disease category was calculated as a percentage reported to the whole population of participating patients over the age of 18 years, regardless of whether this diagnosis was isolated or associated with others, in order to provide a complete picture of morbidity cared for in general practice.

Among adults over 18 years, associations of age, gender, education, type of insurance and 13 broad disease categories with lower MCS and PCS scores (defined as below the first quartile with scores of 34 and 39 for MCS and PCS, respectively) were evaluated using multivariate logistic regression. Odds ratios (OR) and 95% CI are presented for each of these factors. In addition, the same analysis was conducted for the two remaining categories, pregnancy follow-up and preventive motives, which were not considered in the multivariate analysis. The association between the number of comorbidities and the two SF-12 composite scores was tested using linear regression. The possibility of a clustering effect at the practice level was tested using Generalised Estimating Equations multivariate models. We used SAS statistical software (V.9.1) for data analysis. The present study was reported following the 'Strengthening the Reporting of Observational Studies in Epidemiology' statement for cross-sectional studies.[@b27]

Results
=======

The sequential recruitment of physicians was carried out by random stratified sampling from the phone directory for GPs. Among the 3345 GPs initially contacted, 428 (12.8%) agreed to participate in the survey. At the end of recruitment in July 2008, an additional sample of 13 861 GPs were contacted to ensure a representative sample of GPs from all types of primary care practice in France (strictly allopaths, homeopaths and mixed practice). Despite the intrusive nature of the survey, allowing trained research assistants to collect data directly in the waiting room at the medical practice on the very day of consultation, a final sample of 825 participating GPs recruited a total of 11 809 patients eligible for the present study. Of these, 174 were unaccompanied minors, 315 were non-French speakers, 109 had severe psychiatric disorders, 2151 declined participation, 408 were beyond the maximum number possible to be interviewed within the allocated time on site, and 93 had incomplete data and were excluded, allowing a total of 8559 patients for the present analysis.

Physicians
----------

The median age of physicians was 52 years (IQR=33--57) and of these, 24% were women; 54% worked in solo medical practice, 40% worked with other GPs, and 6% collaborated with specialists or other healthcare professionals; 31% of the GPs practised additional medical activities within hospitals, healthcare centres, the health administration or the pharmaceutical industry. Most of the GPs (90%) hold a regular contract with the National Health Insurance organisation, while 9% hold a special contract allowing extra fees; a very small proportion (0.4%) had no contract. The mean daily working time at the practice (excluding home visits) was 9 h (IQR: 2--10.5), and each of the 825 GPs participating in the study recruited on average 8.7 patients (SD 2.2).

Patients
--------

The characteristics of participating (n=8559) and non-participating patients with complete data (n=3157) used to calibrate the sample are presented in [table 1](#tbl1){ref-type="table"}. We report here the results based on weighted characteristics. The mean age of the 8559 participating patients was 44.9 years (SD 21.9), and 7133 (83.3%) were adults over 18. At least 44% of patients had a secondary-school degree, 16% were overweight (BMI\>30 kg/m^2^), and more than 61% exercised longer than 31 min per day. Nine out of ten patients were French-born (90%), 9% were covered by a government-funded insurance for low-income people, and 90% had a private supplementary insurance. Among the 8559 patients, 8% had attended the practice for the first time, 12% had attended for 1 year or less, 27% had attended between 1 and 5 years, and 53% had attended for 5 years or more. Over 84% of participants named the recruiting physician as their regular treating physician. About 28% of patients were registered by the national health insurance as having multiple or severe chronic diseases and requiring special health insurance coverage.

###### 

Characteristics of non-participating and participating patients: results of the calibrated data (Etude épidémiologique de l\'Impact de santé public sur 3 groupes de pathologies (EPI3) survey 2008)

                                                                                                                                       Non-participants[\*](#table-fn1){ref-type="table-fn"}(n=3157)   Participants (n=8559)   Weighted percentage
  ------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------- ----------------------- ---------------------
  Mean (SD)                                                                                                                                                                                                                    
   Age (years)                                                                                                                         47.7 (24.0)                                                     43.3 (22.8)             44.9 (21.9)
  n (%)                                                                                                                                                                                                                        
   Female gender                                                                                                                       1701 (53.9)                                                     5367 (62.7)             57.9
   Length of relationship with the physician                                                                                                                                                                                   
   First time                                                                                                                          265 (8.4)                                                       782 (9.1)               7.7
    \<1 year                                                                                                                           316 (10.0)                                                      1315 (15.4)             11.9
    1--5 years                                                                                                                         743 (23.5)                                                      2380 (27.8)             27.4
    More than 5 years                                                                                                                  1703 (53.9)                                                     4015 (46.9)             53.0
   Government-funded health insurance                                                                                                  308 (9.8)                                                       621 (7.4)               9.4
   Longstanding disease status                                                                                                                                                                         1925 (22.5)             27.7
   Complementary health insurance                                                                                                                                                                      7839 (91.6)             90.3
   Index physician declared as treating physician                                                                                                                                                      6379 (74.5)             84.3
   Body mass index (kg/m^2^)                                                                                                                                                                                                   
    \<25                                                                                                                                                                                               5548 (64.8)             52.4
    25--30                                                                                                                                                                                             2045 (23.9)             31.8
    30 and over                                                                                                                                                                                        966 (11.3)              15.8
   Tobacco consumption                                                                                                                                                                                                         
    Non-smoker                                                                                                                                                                                         4303 (50.3)             47.4
    Past smoker                                                                                                                                                                                        1961 (22.9)             24.4
    Current smoker                                                                                                                                                                                     2252 (26.3)             28.2
   Alcohol consumption                                                                                                                                                                                                         
    Never                                                                                                                                                                                              2908 (34.2)             35.2
    Sometimes                                                                                                                                                                                          4649 (54.6)             52.5
    Daily                                                                                                                                                                                              957 (11.2)              12.4
   Physical exercise                                                                                                                                                                                                           
    \<10 min per day                                                                                                                                                                                   2235 (26.1)             28.3
    10 min and over                                                                                                                                                                                    6199 (72.4)             71.7
   Nationality                                                                                                                                                                                                                 
    French-born subjects                                                                                                                                                                               7787 (91.0)             90.3
    French born abroad                                                                                                                                                                                 341 (4.0)               4.7
    Non-French nationality                                                                                                                                                                             357 (4.2)               5.0
   Educational attainment                                                                                                                                                                                                      
    Secondary-school degree[\*](#table-fn1){ref-type="table-fn"}[†](#table-fn2){ref-type="table-fn"}, college, university graduation                                                                   4179 (48.8)             44.0
   Employment status                                                                                                                                                                                                           
    Employed                                                                                                                                                                                           4544 (53.1)             50.4
    On unemployment benefits                                                                                                                                                                           378 (4.4)               4.7
    Homemaker                                                                                                                                                                                          647 (7.6)               6.6
    Retired and other unemployed                                                                                                                                                                       2562 (29.9)             34.3
    Student                                                                                                                                                                                            348 (4.1)               4.1

Available characteristics used for calibration.

French baccalaureate.

Burden of 100 diseases in primary care
--------------------------------------

The prevalence of each of the 100 and 13 broad non-exclusive diagnosis categories (a compilation of all five diagnoses recorded by the GPs) is presented in [table 2](#tbl2){ref-type="table"}. Altogether, diseases of the musculoskeletal system were the most frequently diagnosed conditions (29%), followed by cardiovascular diseases (26.7%), and sleep, anxiety and depressive disorders (22%). Preventive-care consultations, vaccinations and consultation for administrative purposes accounted for 19% of the total diagnoses. Almost half the patients (49%) exhibited two or more comorbidities.

###### 

Morbidity rates and 12-Item Short Form questionnaire mental and physical component scores according to 100 International Classification of Diseases diagnoses (Etude épidémiologique de l\'Impact de santé public sur 3 groupes de pathologies (EPI3)-LA-SER-2008, weighted data n=7133)

  Diseases                                                                 Morbidity[\*](#table-fn3){ref-type="table-fn"}   PCS           MCS
  ------------------------------------------------------------------------ ------------------------------------------------ ------------- -------------
  All patients                                                                                                              45.6 (8.8)    41.5 (8.6)
  Diseases of the musculoskeletal system                                   2069 (29.0)                                      42.7 (8.4)    41.6 (8.3)
   Osteoarthritis                                                          324 (4.5)                                        41.1 (10.7)   41.7 (11.0)
   Unspecified joint disorders                                             171 (2.4)                                        42.5 (9.9)    42.6 (10.2)
   Intervertebral and cervical disc disorders                              276 (3.9)                                        44.0 (11.4)   40.6 (10.3)
   Lumbago                                                                 360 (5.0)                                        42.1 (10.1)   41.6 (9.4)
   Rotator cuff syndrome of shoulder and allied disorders                  98 (1.4)                                         42.5 (10.1)   42.0 (9.8)
   Other affections of shoulder region                                     121 (1.7)                                        42.6 (9.7)    42.4 (9.1)
   Enthesopathy of elbow region                                            77 (1.1)                                         41.8 (9.3)    43.1 (10.5)
   Unspecified enthesopathy                                                257 (3.6)                                        42.3 (10.5)   42.1 (10.0)
   Rheumatism, excluding the back                                          112 (1.6)                                        42.9 (10.1)   42.3 (9.8)
   Spondylosis and other inflammatory spondylopathies                      84 (1.2)                                         42.1 (9.9)    43.1 (8.4)
   Sciatica                                                                194 (2.7)                                        42.3 (10.1)   41.7 (9.6)
   Pain in thoracic spine                                                  51 (0.7)                                         42.6 (9.8)    41.3 (9.2)
   Osteoporosis                                                            162 (2.3)                                        44.0 (10.7)   41.9 (10.8)
   Diseases of connective tissue                                           36 (0.5)                                         45.5 (9.3)    40.5 (10.9)
   Unspecified back disorders                                              193 (2.7)                                        42.1 (10.2)   41.3 (9.7)
   Other unspecified musculoskeletal disorders                             76 (1.1)                                         40.3 (11.0)   41.7 (11.6)
  Hypertension, cardiovascular and circulatory diseases                    1904 (26.7)                                      43.7 (9.0)    42.5 (8.6)
   Hypertension                                                            1111 (15.6)                                      43.9 (11.3)   42.8 (10.7)
   Acute myocardial infarction                                             84 (1.2)                                         40.8 (11.4)   42.0 (9.4)
   Other symptoms involving cardiovascular system                          53 (0.7)                                         46.0 (9.5)    43.7 (8.2)
   Angina pectoris                                                         66 (0.9)                                         41.8 (11.8)   43.7 (10.5)
   Cardiac dysrhythmias                                                    139 (1.9)                                        42.9 (11.5)   42.7 (11.1)
   Diseases of veins and lymphatics                                        92 (1.3)                                         45.3 (10.5)   41.3 (10.8)
   Pulmonary, artery and cerebrovascular diseases                          144 (2.0)                                        42.1 (11.7)   42.7 (10.6)
   Other ischaemic heart diseases                                          96 (1.3)                                         41.1 (11.9)   42.1 (11.1)
   Other diseases of the circulatory system                                229 (3.2)                                        45.3 (10.3)   41.8 (11.0)
  Anxiety, depression and sleep disorders                                  1569 (22.0)                                      44.8 (8.9)    36.3 (8.5)
   Psychotic conditions                                                    68 (1.0)                                         44.2 (12.6)   37.6 (12.3)
   Anxiety states                                                          420 (5.9)                                        47.8 (10.5)   35.5 (9.7)
   Dysrhythmia                                                             182 (2.6)                                        47.2 (10.2)   35.4 (9.2)
   Acute and chronic stress                                                85 (1.2)                                         46.9 (10.6)   36.1 (9.5)
   Personality disorders, disturbance of conduct and dependence syndrome   81 (1.1)                                         46.4 (10.9)   38.8 (11.2)
   Eating disorders, tics, stuttering and other syndromes                  277 (3.9)                                        47.4 (10.4)   37.1 (10.7)
   Depressive disorders                                                    497 (7.0)                                        45.3 (11.4)   33.0 (10.2)
   Malaise and fatigue                                                     114 (1.6)                                        45.4 (11.1)   38.7 (9.7)
   Sleep disorders                                                         87 (1.2)                                         46.1 (10.7)   38.5 (9.4)
   Nervousness, cachexia and unspecified psychological distress            30 (0.4)                                         41.9 (13.5)   39.9 (12.8)
   Dizziness and giddiness                                                 59 (0.8)                                         46.3 (9.8)    40.2 (10.4)
   Other general symptoms                                                  75 (5.8)                                         46.0 (11.1)   39.2 (10.4)
  Diseases of the respiratory system                                       1419 (19.9)                                      46.3 (8.5)    41.9 (8.4)
   Acute nasopharyngitis                                                   306 (4.3)                                        48.2 (9.8)    41.6 (9.7)
   Acute pharyngitis                                                       60 (0.8)                                         49.3 (10.4)   42.5 (10.5)
   Acute tracheitis                                                        120 (1.7)                                        48.4 (10.1)   41.4 (10.4)
   Acute bronchitis or other upper-respiratory infections                  66 (0.2)                                         41.9 (12.3)   43.0 (8.0)
   Chronic nasopharyngitis                                                 52 (0.3)                                         50.0 (8.1)    42.9 (8.7)
   Chronic sinusitis and laryngitis                                        126 (1.7)                                        48.0 (9.9)    40.3 (8.9)
   Allergic rhinitis                                                       124 (1.7)                                        47.5 (10.7)   42.3 (9.6)
   Pneumonia and flu                                                       53 (0.6)                                         46.8 (10.2)   41.1 (10.8)
   Chronic obstructive pulmonary diseases (except asthma)                  160 (2.2)                                        44.8 (10.4)   41.2 (10.0)
   Asthma                                                                  148 (2.1)                                        44.0 (11.5)   41.4 (10.5)
   Lung diseases                                                           64 (0.9)                                         41.0 (12.3)   42.0 (9.5)
   Other diseases of the respiratory system                                210 (2.9)                                        45.1 (11.6)   42.4 (10.4)
  Medical exams and preventive motives                                     1101 (15.4)                                      47.4 (9.2)    42.4 (10.1)
   Medical exam: handicap influencing health status                        41 (0.6)                                         45.9 (9.4)    39.4 (12.6)
   Medical exam: aftercare and specific procedures                         285 (4.0)                                        45.9 (11.6)   41.2 (10.8)
   Medical exam for health check-up                                        286 (4.0)                                        46.9 (11.3)   43.1 (10.8)
   Laboratories findings                                                   53 (0.7)                                         48.5 (9.8)    42.9 (10.9)
   Vaccination                                                             121 (1.7)                                        50.2 (11.0)   42.6 (10.5)
   Pregnancy follow-up                                                     122 (1.7)                                        47.4 (11.8)   41.8 (10.4)
   Administrative purposes                                                 380 (5.3)                                        47.2 (11.7)   42.5 (9.9)
  Diabetes, thyroid gland and other endocrine disorders                    785 (11.0)                                       43.9 (8.6)    41.5 (8.1)
   Hypothyroidism                                                          187 (2.6)                                        45.3 (11.0)   39.6 (10.9)
   Goitre                                                                  45 (0.6)                                         46.5 (9.3)    41.3 (9.8)
   Diabetes mellitus                                                       312 (4.4)                                        42.9 (11.2)   42.0 (10.5)
   Diseases of other endocrine glands                                      78 (1.1)                                         43.9 (11.9)   41.0 (10.8)
   Other thyroid disorders                                                 52 (0.7)                                         45.7 (10.8)   40.0 (10.1)
  Obesity and dyslipidaemia                                                742 (10.4)                                       45.2 (9.1)    42.0 (8.9)
   Hypercholesterolaemia                                                   266 (3.7)                                        45.1 (10.9)   42.6 (10.2)
   Unspecified disorder of lipoid metabolism                               135 (1.9)                                        45.5 (10.5)   42.8 (9.2)
   Overweight, obesity and other hyperalimentation                         169 (2.4)                                        47.6 (11.4)   40.2 (10.4)
   Other hyperlipidaemia                                                   105 (1.1)                                        45.6 (11.3)   42.4 (10.6)
   Other symptoms concerning nutrition, metabolism and development         70 (1.0)                                         48.6 (10.1)   40.3 (10.4)
  Diseases of the digestive system                                         742 (10.4)                                       45.9 (8.4)    39.9 (8.4)
   Oesophageal diseases                                                    81 (1.1)                                         44.3 (10.3)   41.5 (9.8)
   Diseases of stomach                                                     121 (1.7)                                        45.6 (10.0)   40.1 (9.7)
   Diseases of intestines and peritoneum                                   72 (1.0)                                         45.1 (10.1)   40.2 (9.9)
   Symptoms involving the abdomen                                          161 (2.3)                                        46.9 (10.4)   39.9 (11.0)
   Non-infectious enteritis and colitis                                    105 (1.5)                                        47.5 (9.5)    41.8 (9.9)
   Diseases of oral cavity, salivary glands and jaws                       39 (0.5)                                         49.0 (8.8)    40.3 (10.0)
   Appendicitis and hernia                                                 43 (0.6)                                         44.1 (10.6)   40.0 (10.2)
   Other diseases of the digestive system                                  144 (2.0)                                        44.8 (10.8)   39.7 (9.9)
  Diseases of the nervous system, head and neck                            449 (6.3)                                        43.3 (9.4)    39.6 (9.1)
   Disorders of the central nervous system                                 95 (1.3)                                         41.3 (13.6)   42.2 (11.2)
   Migraine                                                                114 (1.6)                                        46.6 (10.2)   39.7 (10.1)
   Symptoms involving the head and neck                                    96 (1.3)                                         46.3 (10.8)   40.8 (10.2)
   Diseases of the eye                                                     54 (0.7)                                         51.8 (9.9)    37.4 (10.6)
   Diseases of the ear and mastoid processes                               112 (1.6)                                        46.9 (10.8)   41.6 (11.0)
   Other disorders of the nervous system and sense organs                  145 (2.0)                                        44.6 (10.3)   39.9 (10.6)
  Diseases of the genitourinary system                                     400 (5.6)                                        45.5 (9.6)    41.5 (8.9)
   Cystitis                                                                115 (1.6)                                        47.9 (11.5)   40.3 (10.2)
   Diseases of male genital organs                                         85 (1.2)                                         46.0 (10.9)   43.0 (11.0)
   Diseases of female genital organs                                       139 (1.9)                                        48.4 (11.3)   39.8 (10.8)
   Nephrosis and nephritis                                                 86 (1.2)                                         44.8 (11.6)   41.7 (10.6)
   Complications of pregnancy and congenital anomalies                     42 (0.6)                                         43.5 (12.8)   40.4 (10.5)
  Injury and poisoning                                                     342 (4.8)                                        43.5 (9.2)    43.5 (8.3)
   Fractures, sprains and dislocations                                     103 (1.4)                                        41.9 (10.5)   45.3 (9.7)
   Traumas and injuries to organs                                          54 (0.8)                                         44.3 (12.9)   44.1 (11.4)
   Burns and amputations                                                   62 (0.9)                                         44.4 (11.6)   43.1 (10.4)
   Intoxications and allergies to toxic drugs                              108 (1.5)                                        47.3 (11.6)   41.5 (10.7)
   Poisoning, other allergy and side effect of surgery                     55 (0.8)                                         44.3 (11.1)   40.3 (9.3)
  Cancer and infrequent diseases                                           289 (4.1)                                        42.0 (9.3)    40.4 (8.5)
   Neoplasms                                                               174 (2.4)                                        41.8 (11.6)   40.7 (10.6)
   Benign tumours                                                          54 (0.8)                                         44.7 (10.9)   40.8 (10.7)
   Blood diseases                                                          56 (0.8)                                         45.3 (11.1)   41.2 (9.5)
  Skin and subcutaneous tissue diseases                                    243 (3.4)                                        48.8 (7.8)    41.7 (9.6)
   Infections of skin and subcutaneous tissue                              55 (0.8)                                         46.1 (11.0)   40.4 (11.3)
   Inflammatory conditions of skin and subcutaneous tissue                 163 (2.3)                                        47.3 (9.9)    42.2 (10.4)
   Other diseases of skin and subcutaneous tissue                          89 (1.2)                                         49.7 (8.5)    40.1 (11.0)
  Infectious diseases                                                      228 (3.2)                                        47.1 (7.6)    40.7 (7.1)
   Parasitic diseases                                                      76 (1.1)                                         47.1 (11.1)   42.1 (10.7)
   Bacterial diseases                                                      82 (1.1)                                         47.0 (10.0)   39.9 (9.8)
   Viral diseases (including HIV)                                          122 (1.7)                                        46.5 (11.6)   40.5 (10.1)
   Fever and other physiological disturbances of temperature regulation    77 (1.1)                                         46.3 (10.4)   40.1 (8.4)

Each condition category is non-exclusive.

Overall mean scores for PCS and MCS were 45.6 (SD 8.8) and 41.5 (SD 8.6), respectively. Considering PCS, scores ranged from 40.3 (SD 11.0) for one group of unspecified musculoskeletal conditions to 50.2 (SD 11.0) for vaccinations. On the whole, musculoskeletal disorders had the lowest scores with the cancer and other severe diseases category, while skin-related diseases, preventive-care consultation and infectious diseases showed the highest PCS. With regard to MCS, scores ranged from 33.0 (SD 10.2) for depressive disorders to 45.3 for patients with fractures, sprains or dislocation. Overall, the lowest scores were found among patients with mood and sleep disorders, while injury, preventive motives and cardiovascular diseases exhibited the highest scores. Both MCS and PCS decreased significantly with increasing numbers of comorbidities ([figure 1](#fig1){ref-type="fig"}). For example, MCS decreased from 43.3 for patients seeking preventive care advice to 38.5 for those with four diagnoses or more (p for trend \<0.0001) and PCS from 49.2 to 40.4 (p for trend \<0.0001).

![Health-related quality of life: 12-Item Short Form questionnaire (SF-12) mental (MCS) and physical (PCS) component scores per number of comorbidities Etude épidémiologique de l\'Impact de santé public sur 3 groupes de pathologies (EPI3)-2008 (weighted data).](bmjopen-2011-000215fig1){#fig1}

Determinants of health-related quality of life
----------------------------------------------

The associations between patient characteristics and 13 broad categories of diseases are presented in [table 3](#tbl3){ref-type="table"}. A low PCS was significantly associated with an older age (OR=2.48; 95% CI 2.08 to 2.96 for patients over 75 years as compared with adults between 18 and 44 years). A low PCS was negatively associated with a high educational attainment (OR=0.65; 95% CI 0.59 to 0.72 for secondary-school level or higher in comparison with lower educational level), while low MCS scores were associated with gender (OR=1.62; 95% CI 1.45 to 1.81 for women as compared with men) and younger age. Government-funded health-insurance cover was associated with both poor PCS and MCS (OR=1.38; 95% CI 1.15 to 1.65 and OR=1.42; 95% CI 1.19 to 1.70, respectively).

###### 

Health-related quality of life: 12-Item Short Form questionnaire, with Factors and 13 broad diagnoses associated with mental component score and physical component score below the 25th percentile (OR from multivariable logistic regression models adjusted for age, gender, education level, insurance coverage and 13 categories of diseases (aOR) and 95% CI), for Etude épidémiologique de l\'Impact de santé public sur 3 groupes de pathologies (EPI3)-LA-SER-2008 (weighted data)

                                                              Low physical component score   Low mental component score          
  ----------------------------------------------------------- ------------------------------ ---------------------------- ------ --------------
  Age (years)                                                                                                                    
   18--44                                                     1                              1                            1      1
   45--64                                                     1.22                           1.08 to 1.39                 0.96   0.85 to 1.08
   65--74                                                     1.47                           1.25 to 1.73                 0.65   0.55 to 0.78
   75 and over                                                2.48                           2.08 to 2.96                 0.70   0.57 to 0.86
  Gender: female versus male                                  1.03                           0.93 to 1.14                 1.62   1.45 to 1.81
  Education: secondary school degree versus lower diploma     0.65                           0.59 to 0.72                 1.00   0.90 to 1.11
  Government-funded insurance (vs regular health insurance)   1.38                           1.15 to 1.65                 1.42   1.19 to 1.70
  Diseases of the musculoskeletal system                      2.31                           2.08 to 2.57                 0.95   0.85 to 1.06
  Cardiovascular diseases                                     1.22                           1.08 to 1.38                 0.84   0.73 to 0.96
  Anxiety, depression and sleep disorders                     0.99                           0.88 to 1.11                 3.58   3.22 to 3.98
  Diseases of the respiratory system                          1.03                           0.91 to 1.18                 0.91   0.80 to 1.04
  Obesity and dyslipidaemia                                   0.79                           0.67 to 0.94                 0.93   0.78 to 1.11
  Diabetes, thyroid gland and other endocrine disorders       1.15                           0.97 to 1.35                 1.18   0.99 to 1.41
  Diseases of the digestive system                            1.01                           0.86 to 1.19                 1.15   0.89 to 1.38
  Diseases of the genitourinary system                        0.95                           0.76 to 1.19                 1.11   0.89 to 1.38
  Diseases of the nervous system, head and neck               1.24                           1.02 to 1.51                 1.07   0.88 to 1.31
  Skin and subcutaneous tissue diseases                       0.68                           0.51 to 0.90                 0.92   0.71 to 1.19
  Bacterial, viral and parasitic systemic diseases            1.17                           0.89 to 1.54                 1.12   0.86 to 1.48
  Injury and poisoning                                        1.88                           1.52 to 2.33                 0.80   0.61 to 1.03
  Other diseases (cancer and infrequent diseases)             1.73                           1.38 to 2.16                 1.35   1.06 to 1.72

aOR, adjusted odds ratio.

With regard to the disease categories, musculoskeletal diseases (OR=2.31; 95% CI 2.08 to 2.57), injury and poisoning (OR=1.88; 95% CI 1.52 to 2.33), other diseases including cancer (OR=1.73; 95% CI 1.38 to 2.16), diseases of the nervous system, head and neck (OR=1.24; 95% CI 1.02 to 1.51) and cardiovascular diseases (OR=1.22; 95% CI 1.08 to 1.38) were significant predictors of lower PCS score, whereas the opposite was found for skin and subcutaneous tissue diseases (OR=0.68; 95% CI 0.51 to 0.90) or with obesity and dyslipidaemia (OR=0.79; 95% CI 0.67 to 0.94). Significantly poor MCS were observed in patients suffering from anxiety, depression and sleep disorders (OR=3.58; 95% CI 3.22 to 3.98), and experiencing 'other diseases' including cancer (OR=1.35; 95% CI 1.06 to 1.72). Conversely, OR for MCS was significantly decreased for patients with cardiovascular diseases (OR=0.84; 95% CI 0.73 to 0.96). Testing the effect of clustering at the practice level yielded similar results, but to ensure parsimony of the generated models it was decided not to report such effects.

Discussion
==========

The EPI3 survey is, to our knowledge, the first nationwide survey in general practice to provide 100 reference figures for burden of disease assessment, combining both on-site independent recruitment of a large number of patients and additional medical information from GPs. On-site selection and recruitment by an independent investigator limited the possibility of selection bias among patients, and the participation of physicians added high specificity to medical data collection.

There is a clear need for more data on QOL of patients.[@b6] In the UK, the General Practice Research Database assembled a very large sample of 400 surgeries and 2500 individual GPs, providing detailed information on health conditions besides prescriptions, but to our knowledge not on patients\' QOL.[@b3] The Dutch national survey of general practice carried out in 1987 and 2001 gives an assessment of quality of care, but only provided by the patients themselves.[@b2]

The EPI3 survey found a similar prevalence for both diseases[@b10] [@b28] and comorbidities[@b7] [@b9] [@b10] [@b13] as in several other studies, which indicate a good representativeness of our weighted sample. Musculoskeletal and psychological disorders were experienced by more than half the patients attending physicians during the course of the study and represented a significant case load at GP practices. When both physical- and mental status impairment and prevalence are considered, our study further highlighted the heaviest burden of musculoskeletal disorders.

With regard to physical status, the EPI3 survey showed a similar average PCS score to other primary-care[@b7] [@b8] [@b10] [@b11] or disease-specific[@b14] [@b15] [@b29] surveys using the SF-12 or SF-36 questionnaires. The mean PCS were lower than reference values computed in the French reference sample[@b21] and in the 2003 Household survey (JL Lanoe, unpublished data, 2003). Within practices, older age,[@b30; @b31; @b32; @b33] low education attainment and government-funded insurance[@b30] [@b32] [@b33] were associated with lower PCS. When disease categories were considered, musculoskeletal diseases were associated with the lowest PCS,[@b8] [@b34] [@b35] with PCS of similar magnitude to other European surveys including musculoskeletal diseases patients.[@b29]

Regarding mental status, although socio-demographic characteristics had a similar impact on MCS, the EPI3 survey showed significantly lower MCS scores than other studies in general practice.[@b7] [@b8] [@b10] [@b11] Additional comorbidities, which were reported for half of the EPI3 survey sample, could not alone explain this difference with other studies: MCS usually scored an average three points lower than those of patients with one morbidity.[@b16] We believe that our findings could be explained instead by a different methodology: in all other studies conducted in general practice,[@b7] [@b8] [@b10] [@b11] mostly including a small number of medical practices,[@b8] [@b10] [@b11] [@b13] physicians may have selected participants. Our study was free from this bias in view of the selection of consecutive eligible patients in the GP\'s waiting room. In studies in which patients were interviewed for targeted mental disorders[@b15] or when MCS were assessed among patients seeking specialty care,[@b36] [@b37] MCS measures were somewhat similar to ours. In the EPI3 survey, psychological and psychiatric diseases had the greatest negative impact on mental function consistent with other surveys in primary care[@b7] [@b10]; it must be appreciated that associated MCS values were more similar to those of another study conducted on patients with specific psychiatric disorders.[@b15] Lower MCS may thus highlight the overall burden of psychological distress and related diseases of patients seen in primary care.

Strengths and limitations of the study
--------------------------------------

Among the main strengths of our study, the unique combined data from patients and physicians allowed provision of reference figures for the vast majority of diseases encountered in primary care for a large number of patients. Quality-adjusted life years are usually estimated for health economics and mainly derived from QOL measures assessed from EuroQoL standardised instruments (EQ5D).[@b1]Interestingly, the conversion of SF-12 values into EQ5D Utility values has been recently documented,[@b38] suggesting that our results could be extended for that purpose as previously reported.[@b39]

Aditionally, SF-12 questionnaires have been found to provide reliable QOL measurement across studies,[@b22] [@b24] even among patients with acute conditions.[@b40] Although its validity in older patients is moderate,[@b41] our sample was representative of the general population, thus minimising this possible bias on our results.

Finally, a lack of representativeness was an important limitation in other studies.[@b11] [@b42] The sample size of physicians participating in the EPI3 survey is within the range established for other French surveys (from 100 to 1006).[@b26] Physicians were randomly selected from the national telephone directory, which includes general practitioners currently practising in primary care. This was preferred to professional registries of physicians, which lists all registered GPs, regardless of whether they are currently practising or not.

The weighted geographical distribution of the 825 GPs participating in the survey was similar to the national distribution of GPs in private practice across the 22 French regions surveyed, and the distribution of physicians\' individual characteristics regarding age, gender type of contract with national health insurance and type of practice differed only slightly from national statistics[@b26]: female participation was slightly lower (23.5% compared with 26% in the IRDES sample), but the distribution between sectors was similar (8.9% vs 8.5% in sectors 1 and 2, respectively).

In terms of the representativeness of the patients, the calibrated sample of the EPI3 survey was compared with other nationwide studies and has demonstrated its efficiency through other criteria that were not used in the calibration.[@b28] For instance, patients registered by health insurance as eligible to the 'longstanding disease' programme accounted for 28% in the EPI3 survey, which is very similar to the 27% in national census among GP patients.[@b28]

Our study also had several limitations. First, as outlined earlier, requirement to collect very specific data was quite intrusive, leading to a relatively low response rate from the GPs. However, stratified recruitment phases and sample sizes from both GPs and patients highly representative of national standards ensured strong external validity of the results. Second, we did not include an assessment of home consultations, common among GPs in France,[@b27]which could have led to an underestimation of burden of disease. Finally, a multiplicative effect of morbidity which has been found to be associated with QOL impairment was not assessed in our study. Some authors suggested using severity scores to complement the information on morbidity[@b12] [@b13]and assess the impact of multimorbidity, which have already been tackled here but will be the subject of further development in future research within the EPI3 research project. It was a deliberate choice to provide an instant overview of general practice across France and the burden of a large pattern of diseases on patients\' QOL as shown in previous studies which also described an independent effect of diseases on QOL.[@b9; @b10; @b11]

Conclusion
==========

The EPI3 survey is the first nationwide study to report reference values for the burden of 100 different diseases in general practice, collected from a large representative sample of patients attending primary care practices. Our findings suggest that mental impairment may be underestimated in general practice. Ongoing development of healthcare policies and clinical guidelines on the treatment of diseases should rely on a direct assessment of QOL and morbidities in GP medical practices.

GPs foster continuous care, sometimes requiring highly specialised therapy to deal with comorbidities and complex situations. The present study shows that the burden of diseases in primary care is high but also can be diverse. The EPI3 survey provides information on the overall burden of diseases in general practice along with the QOL of patients regarding comorbidities as seen in this healthcare setting. This information is of great value to public health and economic assessment of healthcare, at a time when QOL is becoming a prevalent factor for care delivery and the development of clinical practice guidelines.
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